Di‐Hwei Hsu

4.7k total citations · 3 hit papers
14 papers, 3.9k citations indexed

About

Di‐Hwei Hsu is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Di‐Hwei Hsu has authored 14 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Di‐Hwei Hsu's work include Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (5 papers). Di‐Hwei Hsu is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (5 papers). Di‐Hwei Hsu collaborates with scholars based in United States, France and Tunisia. Di‐Hwei Hsu's co-authors include Kevin W. Moore, Jean‐Bernard Le Pecq, Jacques Banchereau, Catherine Péronne, Nadia Vezzio, Thierry Defrance, F Rousset, Elisabeth Garcia, Rob Kastelein and S. K. Patel and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Di‐Hwei Hsu

14 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

1992 1.1k citations F Rousset, Elisabeth Garcia et al. Proceedings of the National Academy of Sciences profile →
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

2005 917 citations Michael A. Morse, Jennifer Garst et al. Journal of Translational Medicine profile →
Production and characterization of clinical grade exosomes derived from dendritic cells

2002 600 citations Henry Lamparski, S. K. Patel et al. Journal of Immunological Methods profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Di‐Hwei Hsu United States	11	2.1k	1.9k	1.1k	643	348	14	3.9k
Florence Faure France	30	2.2k 1.1×	3.3k 1.7×	827 0.8×	993 1.5×	226 0.6×	46	4.9k
Zsuzsanna Tabi United Kingdom	31	3.6k 1.7×	2.1k 1.1×	2.0k 1.9×	854 1.3×	580 1.7×	53	5.5k
José Moreno Mexico	30	840 0.4×	752 0.4×	693 0.7×	878 1.4×	267 0.8×	90	2.9k
Richard G. DiScipio United States	35	1.1k 0.5×	2.0k 1.1×	448 0.4×	551 0.9×	239 0.7×	69	4.1k
Timothy M. Clay United States	41	2.6k 1.2×	3.2k 1.7×	747 0.7×	2.2k 3.4×	438 1.3×	97	5.9k
Amy Hobeika United States	34	2.0k 1.0×	2.5k 1.3×	724 0.7×	1.7k 2.6×	222 0.6×	90	4.2k
Jaap Kwekkeboom Netherlands	44	1.4k 0.6×	2.8k 1.5×	688 0.7×	1.7k 2.7×	1.1k 3.2×	161	6.0k
Geoffrey S. Kansas United States	52	2.3k 1.1×	4.5k 2.3×	606 0.6×	1.5k 2.3×	392 1.1×	89	8.5k
Claire Turbide Canada	26	3.1k 1.5×	890 0.5×	1.3k 1.3×	578 0.9×	239 0.7×	39	4.3k
Hinrich P. Hansen Germany	29	1.3k 0.6×	1.5k 0.8×	532 0.5×	949 1.5×	143 0.4×	72	3.2k

Countries citing papers authored by Di‐Hwei Hsu

Since Specialization

Citations

This map shows the geographic impact of Di‐Hwei Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di‐Hwei Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di‐Hwei Hsu more than expected).

Fields of papers citing papers by Di‐Hwei Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di‐Hwei Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di‐Hwei Hsu. The network helps show where Di‐Hwei Hsu may publish in the future.

Co-authorship network of co-authors of Di‐Hwei Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Di‐Hwei Hsu. A scholar is included among the top collaborators of Di‐Hwei Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di‐Hwei Hsu. Di‐Hwei Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Morse, Michael A., Jennifer Garst, Takuya Osada, et al.. (2005). A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. Journal of Translational Medicine. 3(1). 9–9. 917 indexed citations breakdown →

André, Fabrice, Nathalie Chaput, Noël E.C. Schartz, et al.. (2004). Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells. The Journal of Immunology. 172(4). 2126–2136. 418 indexed citations

Hsu, Di‐Hwei, Pedro Paz, Alberto Rivas, et al.. (2003). Exosomes as a Tumor Vaccine: Enhancing Potency Through Direct Loading of Antigenic Peptides. Journal of Immunotherapy. 26(5). 440–450. 138 indexed citations

Lamparski, Henry, et al.. (2002). Production and characterization of clinical grade exosomes derived from dendritic cells. Journal of Immunological Methods. 270(2). 211–226. 600 indexed citations breakdown →

Klingbeil, Corine & Di‐Hwei Hsu. (1999). Pharmacology and Safety Assessment of Humanized Monoclonal Antibodies for Therapeutic Use. Toxicologic Pathology. 27(1). 1–3. 18 indexed citations

Cole, Michael S., Jia Shi, Margit Homola, et al.. (1999). HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IS IMMUNOSUPPRESSIVE TO T CELLS WHILE EXHIBITING REDUCED MITOGENICITY IN VITRO1. Transplantation. 68(4). 563–571. 66 indexed citations

Hsu, Di‐Hwei, Jia Shi, Margit Homola, et al.. (1999). A HUMANIZED ANTI-CD3 ANTIBODY, HuM291, WITH LOW MITOGENIC ACTIVITY, MEDIATES COMPLETE AND REVERSIBLE T-CELL DEPLETION IN CHIMPANZEES. Transplantation. 68(4). 545–554. 35 indexed citations

Eastman, Susan, Michael Deftos, Paul deRoos, et al.. (1996). A study of complexes of class II invariant chain peptide: Major histocompatibility complex class II molecules using a new complex‐specific monoclonal antibody. European Journal of Immunology. 26(2). 385–393. 54 indexed citations

Ho, A S, et al.. (1993). A receptor for interleukin 10 is related to interferon receptors.. Proceedings of the National Academy of Sciences. 90(23). 11267–11271. 188 indexed citations

10.

Rousset, F, Elisabeth Garcia, Thierry Defrance, et al.. (1992). Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.. Proceedings of the National Academy of Sciences. 89(5). 1890–1893. 1061 indexed citations breakdown →

11.

Moore, Kevin W. & Di‐Hwei Hsu. (1990). Structure and expression of cloned Fcγ receptors. Research in Immunology. 141(1). 68–74. 1 indexed citations

12.

Hsu, Di‐Hwei, René de Waal Malefyt, David Fiorentino, et al.. (1990). Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1. Science. 250(4982). 830–832. 418 indexed citations

13.

Monte, Suzanne M. de la, Siew C. Ng, & Di‐Hwei Hsu. (1990). ABERRANT EXPRESSION OF GAP-43 IN ALZHEIMERʼS DISEASE (AD). Journal of Neuropathology & Experimental Neurology. 49(3). 319–319. 2 indexed citations

14.

Hsu, Di‐Hwei, et al.. (1988). A predominant idiotype independent of specificity, or Ig and H‐2 allotypes, is found in the primary but not the secondary murine antibody response to lysozyme. European Journal of Immunology. 18(10). 1567–1574. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact